Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimizing Pain During Office Intradetrussor Botox Injection: A Prospective Randomized Controlled Trial Comparing Two Protocols

NCT04270526 is registered in ClinicalTrials.gov with Boston Urogynecology Associates as lead sponsor.

NCT NCT04270526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimizing Pain During Office Intradetrussor Botox Injection: A Prospective Randomized Controlled Trial Comparing Two Protocols
Lead sponsor
Boston Urogynecology Associates
Phase
Phase 4
Overall status
Completed
Start date
August 15, 2020
Completion date
June 30, 2023
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, overactive bladder syndrome, overactive detrusor, overactivity; behavior, urge incontinence